Ebola Update: Funding, Vaccines, and More Deaths in DRC

A total of 27 people have died since April, but new funds and the deployment of an experimental vaccine are expected to help contain the virus.

Written byCatherine Offord
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

World Health Organization workers deployed medical kits in response to reports of Ebola cases in DRC in 2017.FLICKR, MONUSCOThe US government has committed another $7 million in funds to fighting Ebola in Democratic Republic of Congo, bringing its total contribution to $8 million, according to a press statement yesterday (May 22) by US Secretary of Health and Human Services, Alex Azar. The announcement comes amid reports of another two deaths from the virus in an outbreak that has killed 27 people since April, prompting the first deployment of an experimental vaccine in the region this week.

“The risk of spreading within the country and to neighboring nations remains real,” Fatoumata Nafo-Traoré of the International Federation of Red Cross and Red Crescent Societies tells Reuters. “One of the lessons we learned in our response to other deadly Ebola outbreaks is that complacency can kill.”

Health authorities were widely criticized for failing to respond more quickly to the outbreak of Ebola in West Africa, which claimed more than 11,000 lives between 2013 and 2016. A much faster response to news of eight confirmed cases and four deaths in Democratic Republic of Congo (DRC) early last year resulted in the World Health Organization (WHO) declaring that outbreak over within a few months.

Cases began reappearing in DRC in the rural town of Bikoro earlier ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026, Issue 1

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs
Graphic of three DNA helices in various colors

An Automated DNA-to-Data Framework for Production-Scale Sequencing

illumina
Exploring Cellular Organization with Spatial Proteomics

Exploring Cellular Organization with Spatial Proteomics

Abstract illustration of spheres with multiple layers, representing endoderm, ectoderm, and mesoderm derived organoids

Organoid Origins and How to Grow Them

Thermo Fisher Logo

Products

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control

Biotium Logo

Biotium Launches GlycoLiner™ Cell Surface Glycoprotein Labeling Kits for Rapid and Selective Cell Surface Imaging

Colorful abstract spiral dot pattern on a black background

Thermo Scientific X and S Series General Purpose Centrifuges

Thermo Fisher Logo
Abstract background with red and blue laser lights

VANTAstar Flexible microplate reader with simplified workflows

BMG LABTECH